Found 200 results
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Parker, A., and Goodman, J. R., “Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.”, Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, Inderlied, C. B., and Young, L. S., “Mycobacterium avium complex in AIDS.”, Current clinical topics in infectious diseases, vol. 12, pp. 257-81, 1992.
L. E. Bermudez, Young, L. S., and Gupta, S., “1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF.”, Cellular immunology, vol. 127, no. 2, pp. 432-41, 1990.
L. E. Bermudez, Petrofsky, M., and Sangari, F., “Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.”, Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.
L. E. Bermudez, Wu, M., and Young, L. S., “Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.”, Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S., “Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.”, Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.
L. E. Bermudez, Nash, K., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.”, Antimicrobial agents and chemotherapy, vol. 44, no. 10, pp. 2619-22, 2000.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., “Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”, Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, “The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report.”, Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 19, no. 2, pp. 159-65, 1986.
L. E. Bermudez, Sangari, F. J., and Parker, A., “Green fluorescent protein in the measurement of bacteria-host interactions.”, Methods in enzymology, vol. 302, pp. 285-95, 1999.
L. E. Bermudez and Young, L. S., “Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines.”, The Journal of infectious diseases, vol. 163, no. 6, pp. 1286-92, 1991.
L. E. Bermudez, Petrofsky, M., Sommer, S., and Barletta, R. G., “Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination.”, Infection and immunity, vol. 78, no. 8, pp. 3570-7, 2010.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B., “Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”, The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez and Young, L. S., “Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines.”, Research in microbiology, vol. 141, no. 2, pp. 241-3, 1990.
L. E. Bermudez, “Immunobiology of Mycobacterium avium infection.”, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13, no. 11, pp. 1000-6, 1994.
L. E. Bermudez, “[Use of monoclonal antibodies in the diagnosis and treatment of infection in immunocompromised patients].”, Revista paulista de medicina, vol. 105, no. 6, pp. 341-6, 1987.
L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T., “Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages.”, Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
L. E. Bermudez, Young, L. S., Martinelli, J., and Petrofsky, M., “Exposure to ethanol up-regulates the expression of Mycobacterium avium complex proteins associated with bacterial virulence.”, The Journal of infectious diseases, vol. 168, no. 4, pp. 961-8, 1993.
L. E. Bermudez, Petrofsky, M., and Goodman, J., “Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.”, Infection and immunity, vol. 65, no. 9, pp. 3768-73, 1997.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract.”, The Journal of infectious diseases, vol. 165, no. 1, pp. 75-9, 1992.
L. E. Bermudez and Yamazaki, Y., “Effects of macrolides and ketolides on mycobacterial infections.”, Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. E. Bermudez, Petrofsky, M., Inderlied, C. B., and Young, L. S., “Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.”, The Journal of antimicrobial chemotherapy, vol. 36, no. 4, pp. 641-6, 1995.
L. E. Bermudez, Wu, M., Enkel, H., and Young, L. S., “Naturally occurring antibodies against Mycobacterium avium complex.”, Annals of clinical and laboratory science, vol. 19, no. 6, pp. 435-43, 1989.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., “Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”, Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.

Pages